Acadian Asset Management
KURA icon

Acadian Asset Management’s Kura Oncology KURA Stock Holding History

Acadian Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$397K Sell
36,262
-328,856
-90% -$3.1M ﹤0.01% 1502
2026
Q1 		$2.97M Sell
365,118
-521,461
-59% -$4.48M ﹤0.01% 839
2025
Q4 		$9.21M Sell
886,579
-174,250
-16% -$1.83M 0.02% 503
2025
Q3 		$9.39M Buy
1,060,829
+189,926
+22% +$1.35M 0.02% 493
2025
Q2 		$5.02M Buy
870,903
+540,482
+164% +$3.31M 0.01% 582
2025
Q1 		$2.18M Buy
+330,421
New +$2.57M 0.01% 734
2020
Q2 		– Sell
-7,693
Closed -$77K – 2285
2020
Q1 		$77K Buy
7,693
+6,005
+356% +$68.7K ﹤0.01% 1407
2019
Q4 		$23K Buy
+1,688
New +$25K ﹤0.01% 1707
2019
Q3 		– Sell
-3,016
Closed -$59K – 1944
2019
Q2 		$59K Buy
+3,016
New +$50.1K ﹤0.01% 1452
2018
Q2 		– Sell
-8,701
Closed -$163K – 1779
2018
Q1 		$163K Buy
+8,701
New +$169K ﹤0.01% 1110
2017
Q3 		– Sell
-4,518
Closed -$42K – 1463
2017
Q2 		$42K Sell
4,518
-579
-11% -$5.27K ﹤0.01% 1155
2017
Q1 		$45K Sell
5,097
-2,763
-35% -$20.3K ﹤0.01% 1254
2016
Q4 		$46K Buy
+7,860
New +$42.1K ﹤0.01% 1197

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Acadian Asset Management's KURA Position: Q2 2026 in Review

Acadian Asset Management reduced its Kura Oncology (KURA) stake by 90% in Q2 2026, selling an estimated $3.1M and leaving 36,262 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #1502.

Acadian Asset Management first reported a position in KURA in Q4 2016 and has held it in 13 quarters since. The position peaked at $9.39M in Q3 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Acadian Asset Management held 36,262 shares of Kura Oncology worth $397K as of Q2 2026.
  • Acadian Asset Management sold 328,856 Kura Oncology shares in Q2 2026, an estimated $3.1M.
  • Kura Oncology made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1502 holding.
  • Acadian Asset Management first reported a position in Kura Oncology in Q4 2016 and has held it in 13 quarters since.
  • Acadian Asset Management's Kura Oncology position peaked at $9.39M in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.